Search results for: methotrexate

Rheuminations: Epigenetics May Help to Explain Why Some Get Rheumatic Disease

Simon M. Helfgott, MD | March 1, 2013

Recent research around genes and environmental stresses suggests outside influences can make lasting changes to the genome via epigenetic mechanisms

ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists

Susan Bernstein | March 1, 2013

Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | March 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

William P. Docken MD | March 1, 2013

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

Rheumatology Chooses Wisely

Kurt Ullman | February 22, 2013

ACR identifies five practices, therapies, or procedures physicians and patients should question

What Mick Jagger Can Teach Us About Growing Old Gracefully

Simon M. Helfgott, MD | February 1, 2013

Preventive lifestyle behaviors, including regular exercise, can compress morbidity and disability to the very end of our lives, say rheumatologists

ACR/ARHP Annual Meeting 2012: Rheumatologists Take Proactive Approach in Talking with Teen Patients about Risky Behavior

Susan Bernstein | February 1, 2013

With teenaged juvenile arthritis patients, it’s important for rheumatologists to engage in conversations about how drugs, tobacco, alcohol, and sex will affect them

ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines

Thomas R. Collins | February 1, 2013

People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs

ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus

Susan Bernstein | February 1, 2013

Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE

Aggressive Treatment of Inflammation Prevents Vision Loss in Patients with JIA-related Uveitis

Lara C. Pullen, PhD | January 24, 2013

A new study confirms that the use of immunosuppressive drugs is associated with a reduced risk of vision loss in patients with juvenile idiopathic arthritis-related uveitis.